Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...

According to a doctor, other factors, such as exposure to contaminated needles, could also lead to HIV infections.

PYRUKYND is currently approved in Europe for adults with PK deficiency; thalassemia would represent its second indication, ...

Having expanded access to quantitative hemoglobin variant testing in 40 countries, Hemex is now also setting its sights on the US and Europe.

Agios Pharmaceuticals said a key European regulatory committee has recommended expanded approval of its Pyrukynd anemia drug for certain people with the inherited blood disorder thalassemia. Agios on ...

About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.

aDepartment of Pediatric Hematology, The Affiliated Hospital of Guizhou Medical University, Department of Pediatrics, School of Clinical Medicine, Guizhou Medical University, Guiyang, 550004, China ...

For classical hematologist Srila Gopal, MD, overseeing the care of about 250 adults with sickle cell disease (SCD) and thalassemia isn’t just a matter of diagnosis and treatment. In just a single week ...

Everyone said the right things, refusing to get out ahead of themselves and allowing Matthew Schaefer space to prove he should start the season on the Islanders rather than anointing the 18-year-old.

The ALDS between the Seattle Mariners and Detroit Tigers shifted abruptly to a best-of-three with both teams trading body blows in Games 1 and 2. The Mariners came in confident having been given the ...

Part of the Jacksonville Jaguars' strong start to the 2025 NFL season has been their health. Injuries are a factor in every spot, and they play an especially large role in professional football, due ...